Neurocrine Biosciences

Neurocrine Biosciences

Financial Reporting Manager

US CA San Diego · Senior

Sponsorship not specified$120k-$164kDetected 2 hours ago
ComplianceProject ManagementFinancial AnalysisAccountingFP&AAuditingFDA RegulatoryLeadershipCommunicationCollaborationProblem SolvingOrganizational SkillsGAAPFinancial ReportingInternal Audit

Stay score

odds of building a lasting career here

57Sponsors, lottery-bound
Cap-exempt (no lottery)0
Sponsors this role90
Entry-level history0
PERM / green-card track0
Lottery odds (Level III)83
Fits your clock70

Sponsors, but it's cap-subject — you still face the weighted lottery (~45% per draw at Level III). Good if you win; have a cap-exempt backup on your list.

Lottery odds assume a STEM candidate.

Personalize to your clock →

Employer immigration record

from this employer's Department of Labor filings

Files H-1B transfers

6 transfer filings in the last year, covering 6 workers. Median labor-condition decision: 7 days. An employer that already files transfers is one that can take over an existing H-1B.

Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.

Community outcomes

No reports yet — be the first to help the next applicant.

About the role

  • Coordinate with external auditors on quarterly reviews and annual audits related to financial statements, disclosures, and supporting documentation
  • Coordinate XBRL and Inline XBRL processes, including review of tagging, taxonomy updates, validation results, and final filing packages in partnership with internal and external resources
  • This role will have primary responsibility for coordinating and preparing quarterly and annual SEC filings, administering Workiva and supporting XBRL compliance, and maintaining rigorous financial statement tie-out and disclosure review processes.

Responsibilities

  • Lead and manage the external reporting calendar, establish deliverables and review timelines, coordinate inputs from cross-functional stakeholders, and proactively identify and resolve issues that could affect filing readiness
  • Partner with Legal, Investor Relations, FP&A, Tax, Treasury, Accounting, and other functions to coordinate disclosures and ensure consistency of externally reported information
  • Develop and maintain reporting procedures, templates, checklists, and documentation that support an efficient, repeatable, and well-controlled close-to-file process
  • Identify and implement process and technology improvements that enhance the quality, efficiency, and scalability of external reporting
  • Review underlying support schedules, reconciliations, roll forwards, and supporting documentation, and ensure appropriate linkage to the general ledger and external disclosures
  • Monitor new and emerging SEC and accounting disclosure requirements and assess and implement appropriate changes to the Company's reporting processes and disclosures
  • Maintain and improve process narratives, flowcharts, risk and control matrices, and evidence supporting the external reporting control environment
  • Evaluate reporting processes for control, documentation, and efficiency improvements and help implement sustainable solutions
  • Lead cross-functional reporting workstreams, build consensus among stakeholders, and communicate data-driven conclusions and recommendations to senior leaders

Requirements

  • Strong knowledge of U.S. GAAP and SEC reporting requirements, with demonstrated experience preparing or reviewing Forms 10-Q and 10-K and related financial statement disclosures
  • Experience with SOX 404 compliance, financial reporting controls, and external audit support
  • Clear and effective written and verbal communication skills, including the ability to tailor technical information for different audiences and communicate recommendations to senior leaders
  • Demonstrated ability to provide technical guidance, mentor less-experienced colleagues, and contribute to the development of team capabilities.
  • Ability to anticipate downstream impacts, emerging reporting requirements, risks, and opportunities to improve reporting processes and controls.
  • High attention to detail combined with the ability to understand broader business and financial reporting implications

Nice to have

  • Bachelor's degree in Accounting, Finance, or a related field
  • CPA strongly preferred
  • Typically 6+ years of applicable accounting and financial reporting experience with a bachelor's degree, including public accounting and/or public-company SEC reporting experience
  • Big 4 public accounting experience preferred
  • Hands-on experience with Workiva and XBRL/Inline XBRL strongly preferred

Compensation

  • Lead the preparation and coordination of quarterly and annual SEC filings, including Forms 10-Q and 10-K, and support other SEC filings and financial reporting requirements as needed

Benefits

  • Partner with HR, Legal, Payroll, and external vendors to resolve equity-related accounting and reporting matters and support timely, accurate data flows
  • Lead preparation and review of equity-related financial statement disclosures and supporting tie-outs
  • Lead and support key SOX 404 controls associated with SEC reporting, financial statement preparation, Workiva, stock-based compensation, and related reporting processes

Company info

  • Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. ( *in collaboration with AbbVie )
  • About the Role:
  • We are seeking an experienced SEC Reporting Manager to lead key aspects of the Company's external financial reporting process and related reporting infrastructure. This role will have primary responsibility for coordinating and preparing quarterly and annual SEC filings, administering Workiva and supporting XBRL compliance, and maintaining rigorous financial statement tie-out and disclosure review processes. The Manager will also serve as a key technical resource for stock-based compensation accounting and related disclosures, support SOX 404 activities over financial reporting processes, and partner closely with Accounting, Finance, Legal, HR, Payroll, Internal Audit, external auditors, and other stakeholders. The role requires strong U.S. GAAP and SEC reporting expertise, sound judgment, effective project management, and the ability to translate complex reporting requirements into clear, timely, and accurate deliverables. _
  • Your Contributions (include, but are not limited to):
  • Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs.
  • We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders.
  • The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas.
  • For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions.
  • We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.
  • For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. ( *in collaboration with AbbVie )
  • Biosciences is a leading biopharmaceutical company with a simple purpose:
  • to relieve suffering for people with great needs.
  • We are seeking an experienced SEC Reporting Manager to lead key aspects of the Company's external financial reporting process and related reporting infrastructure.

This listing is sourced directly from Neurocrine Biosciences's careers page and normalized into a canonical job model.